- Home
- IPDN vs TOVX Comparison
IPDN vs TOVX Comparison
Compare IPDN & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPDN
- TOVX
- Stock Information
- Founded
- IPDN 2003
- TOVX 2001
- Country
- IPDN United States
- TOVX United States
- Employees
- IPDN N/A
- TOVX N/A
- Industry
- IPDN EDP Services
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- IPDN Technology
- TOVX Health Care
- Exchange
- IPDN Nasdaq
- TOVX Nasdaq
- Market Cap
- IPDN 4.3M
- TOVX 3.6M
- IPO Year
- IPDN 2013
- TOVX 2006
- Fundamental
- Price
- IPDN $1.75
- TOVX $0.53
- Analyst Decision
- IPDN
- TOVX Hold
- Analyst Count
- IPDN 0
- TOVX 1
- Target Price
- IPDN N/A
- TOVX N/A
- AVG Volume (30 Days)
- IPDN 102.8K
- TOVX 2.5M
- Earning Date
- IPDN 05-19-2025
- TOVX 05-20-2025
- Dividend Yield
- IPDN N/A
- TOVX N/A
- EPS Growth
- IPDN N/A
- TOVX N/A
- EPS
- IPDN N/A
- TOVX N/A
- Revenue
- IPDN $6,730,605.00
- TOVX N/A
- Revenue This Year
- IPDN N/A
- TOVX N/A
- Revenue Next Year
- IPDN N/A
- TOVX N/A
- P/E Ratio
- IPDN N/A
- TOVX N/A
- Revenue Growth
- IPDN N/A
- TOVX N/A
- 52 Week Low
- IPDN $0.97
- TOVX $0.74
- 52 Week High
- IPDN $11.70
- TOVX $12.25
- Technical
- Relative Strength Index (RSI)
- IPDN 52.25
- TOVX 21.24
- Support Level
- IPDN $1.42
- TOVX $1.32
- Resistance Level
- IPDN $1.84
- TOVX $1.45
- Average True Range (ATR)
- IPDN 0.17
- TOVX 0.15
- MACD
- IPDN 0.10
- TOVX -0.09
- Stochastic Oscillator
- IPDN 88.10
- TOVX 5.82
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the Professional Diversity Network (PDN) segment, which includes online professional networking communities with career resources for diverse cultural groups and employers looking to hire members; and the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization, the RemoteMore segment. The company generates majority of its revenue from PDN Segment.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.